Skip to content

ImmunoGen, Inc.: filings

Every ImmunoGen, Inc. annual and quarterly report in the SEC record with the published financial measures it tagged, 48 filings, each linked to its SEC index.

Filing record ends 2023-11-02

The latest filing in this captured record is a 10-Q filed 2023-11-02. No later filing is in the SEC companyfacts record captured on 2026-09-22. ImmunoGen, Inc. may have stopped filing, merged, or changed its reporting entity; nothing on this page describes its current status. Values are as reported at the time.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2023-11-02fiscal Q3 2023431160001558370-23-017411
10-Q2023-07-31fiscal Q2 2023421090001558370-23-012564
10-Q2023-04-28fiscal Q1 202338840001558370-23-007254
10-K2023-03-01fiscal FY 2022451150001558370-23-002558
10-Q2022-11-04fiscal Q3 2022371080001558370-22-016350
10-Q2022-08-01fiscal Q2 2022371060001558370-22-011460
10-Q2022-05-06fiscal Q1 202239850001558370-22-007545
10-K2022-02-28fiscal FY 2021441140001558370-22-002358
10-Q2021-10-29fiscal Q3 202134940001558370-21-013847
10-Q2021-07-30fiscal Q2 202134920001558370-21-009731
10-Q2021-05-10fiscal Q1 202134760001558370-21-006659
10-K2021-03-01fiscal FY 2020401010001558370-21-002170
10-Q2020-11-06fiscal Q3 202034930001558370-20-013027
10-Q2020-08-05fiscal Q2 202034910001558370-20-009337
10-Q2020-05-05fiscal Q1 202034750001558370-20-005161
10-K2020-03-11fiscal FY 2019401600001558370-20-002399
10-Q2019-11-05fiscal Q3 201935920001558370-19-010010
10-Q2019-08-07fiscal Q2 201935900001558370-19-007500
10-Q2019-05-07fiscal Q1 201934730001558370-19-004233
10-K2019-03-01fiscal FY 2018372110001558370-19-001432
10-Q2018-11-02fiscal Q3 201833830001558370-18-008331
10-Q2018-08-03fiscal Q2 201835860001558370-18-006326
10-Q2018-05-09fiscal Q1 201834680001558370-18-004485
10-K2018-03-07fiscal FY 2017372130001558370-18-001641
10-Q2017-11-09fiscal Q3 201732820001558370-17-008679
10-Q2017-08-04fiscal Q2 201732820001558370-17-005987
10-Q2017-05-05fiscal Q1 201728580001558370-17-003635
10-Q2016-11-04fiscal Q1 201728580001558370-16-009369
10-K2016-08-25fiscal FY 2016311290001558370-16-008099
10-Q2016-05-04fiscal Q3 201629780001104659-16-117673
10-Q2016-02-04fiscal Q2 201630820001104659-16-093833
10-Q2015-10-30fiscal Q1 201628580001104659-15-074417
10-K2015-08-27fiscal FY 2015311270001047469-15-007008
10-Q2015-05-08fiscal Q3 201528740001104659-15-036133
10-Q2015-02-05fiscal Q2 201530820001104659-15-006994
10-Q2014-10-30fiscal Q1 201528580001104659-14-075205
10-K2014-08-28fiscal FY 2014311280001047469-14-007236
10-Q2014-05-02fiscal Q3 201429750001104659-14-033996
10-Q2014-02-05fiscal Q2 201431830001104659-14-006659
10-Q2013-10-29fiscal Q1 201429590001104659-13-078598
10-K2013-08-29fiscal FY 2013311300001047469-13-008741
10-Q2013-05-06fiscal Q3 201329750001104659-13-037456
10-Q2013-01-30fiscal Q2 201329750001104659-13-005970
10-Q2012-10-31fiscal Q1 201329590001104659-12-072542
10-K2012-08-29fiscal FY 2012311330001047469-12-008592
10-Q2012-05-10fiscal Q3 201229780001104659-12-035820
10-Q2012-01-31fiscal Q2 201230800001104659-12-005282
10-Q2011-10-31fiscal Q1 201229600001104659-11-059039

Inspect the source

Entity
ImmunoGen, Inc. / CIK 0000855654
Captured
SEC response SHA-256
7b9d0b02fea51577f71df2d429da1b3e4b7fea4c1ef7092402d373d527dad47d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000855654.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))